15th Annual Cardiovascular Disease Update: TRACK TWO

Advances in Arrhythmia Therapy

[Non-CME eligible education program]

Cardiovascular disease is the leading cause of death in the United States for both men and women. Treatment approaches are helping prolong life with improved quality in many patients with advanced heart disease. This symposium will provide an in-depth review of current advances in the care of complex patients with cardiovascular disease. Practitioners should be able to incorporate many of the tips and tools from this case-based program into their daily practice.


Indications Update for Lead Extraction

Sergio Thal, MD, discusses the indications update for lead extraction.
Sergio Thal, MD

Sergio Thal, MD

Director, Lead Management Program, University Hospitals Harrington Heart & Vascular Institute
Clinical Associate Professor, Case Western Reserve University School of Medicine

Afib and HFrEF / HFpEF

Samuel Asirvatham, MD, discusses contemporary management of artial fibrillation in heart failure.
Samuel Asirvatham, MD

Samuel Asirvatham, MD

Director, Clinical Cardiac Electrophysiology Fellowship
Director, Strategic Collaboration for the Center for Innovation
Professor, Medicine and Pediatrics
Mayo Clinic, Rochester, Minnesota

Ventricular Tachycardia: Catheter Ablation, Who When and How?

Jason Bradfield, MD, discusses ventricular tachycardia and catheter ablation.
Jason Bradfield, MD, FACC FHRS

Jason Bradfield, MD, FACC FHRS

Associate Professor of Medicine
Director, Specialized Program for Ventricular Tachycardia
UCLA Cardiac Arrhythmia Center
David Geffen School of Medicine at UCLA

Learn More from the 15th Annual Cardiovascular Disease Update:

TRACK ONE

TRACK THREE

TRACK FOUR

TRACK FIVE